76 related articles for article (PubMed ID: 10886506)
1. Characterization of a transcription factor binding site, specifically activating MIA transcription in melanoma.
Golob M; Buettner R; Bosserhoff AK
J Invest Dermatol; 2000 Jul; 115(1):42-7. PubMed ID: 10886506
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of COOH-terminal binding protein expression in malignant melanomas leads to induction of MIA expression.
Poser I; Golob M; Weidner M; Buettner R; Bosserhoff AK
Cancer Res; 2002 Oct; 62(20):5962-6. PubMed ID: 12384563
[TBL] [Abstract][Full Text] [Related]
3. Melanoma inhibitory activity promotes melanoma development through activation of YBX1.
Schmid R; Meyer K; Spang R; Schittek B; Bosserhoff AK
Pigment Cell Melanoma Res; 2013 Sep; 26(5):685-96. PubMed ID: 23672612
[TBL] [Abstract][Full Text] [Related]
4. The specific activation of gadd45 following UVB radiation requires the POU family gene product N-oct3 in human melanoma cells.
Lefort K; Rouault JP; Tondereau L; Magaud JP; Doré JF
Oncogene; 2001 Nov; 20(50):7375-85. PubMed ID: 11704867
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of the hepatocyte growth factor (HGF) gene by the Sp family of transcription factors.
Jiang JG; Chen Q; Bell A; Zarnegar R
Oncogene; 1997 Jun; 14(25):3039-49. PubMed ID: 9223667
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype.
Poser I; Golob M; Buettner R; Bosserhoff AK
Mol Cell Biol; 2003 Apr; 23(8):2991-8. PubMed ID: 12665595
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.
Lok CN; Lang AJ; Mirski SE; Cole SP
Biochem J; 2002 Dec; 368(Pt 3):741-51. PubMed ID: 12197834
[TBL] [Abstract][Full Text] [Related]
8. Cloning of a 2.5 kb murine bone sialoprotein promoter fragment and functional analysis of putative Osf2 binding sites.
Benson MD; Aubin JE; Xiao G; Thomas PE; Franceschi RT
J Bone Miner Res; 1999 Mar; 14(3):396-405. PubMed ID: 10027904
[TBL] [Abstract][Full Text] [Related]
9. Identification and functional characterization of the human and murine polo-like kinase (Plk) promoter.
Bräuninger A; Strebhardt K; Rübsamen-Waigmann H
Oncogene; 1995 Nov; 11(9):1793-800. PubMed ID: 7478607
[TBL] [Abstract][Full Text] [Related]
10. Distal Sp3 binding sites in the hIGBP-1 gene promoter suppress transcriptional repression in decidualized human endometrial stromal cells: identification of a novel Sp3 form in decidual cells.
Gao J; Tseng L
Mol Endocrinol; 1996 Jun; 10(6):613-21. PubMed ID: 8776721
[TBL] [Abstract][Full Text] [Related]
11. YBX1 is a modulator of MIA/CD-RAP-dependent chondrogenesis.
Schmid R; Meyer K; Spang R; Schittek B; Bosserhoff AK
PLoS One; 2013; 8(12):e82166. PubMed ID: 24349210
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of a novel enhancer for the human MCT-1 oncogene promoter.
Shi B; Levenson V; Gartenhaus RB
J Cell Biochem; 2003 Sep; 90(1):68-79. PubMed ID: 12938157
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
14. Steroidogenic factor-1 interacts with a gonadotrope-specific element within the first exon of the human gonadotropin-releasing hormone receptor gene to mediate gonadotrope-specific expression.
Ngan ES; Cheng PK; Leung PC; Chow BK
Endocrinology; 1999 Jun; 140(6):2452-62. PubMed ID: 10342829
[TBL] [Abstract][Full Text] [Related]
15. [MIA ("melanoma inhibitory activity"). Biological functions and clinical relevance in malignant melanoma].
Bosserhoff AK; Golob M; Buettner R; Landthaler M; Hein R
Hautarzt; 1998 Oct; 49(10):762-9. PubMed ID: 9857251
[TBL] [Abstract][Full Text] [Related]
16. Mouse CD-RAP/MIA gene: structure, chromosomal localization, and expression in cartilage and chondrosarcoma.
Bosserhoff AK; Kondo S; Moser M; Dietz UH; Copeland NG; Gilbert DJ; Jenkins NA; Buettner R; Sandell LJ
Dev Dyn; 1997 Apr; 208(4):516-25. PubMed ID: 9097023
[TBL] [Abstract][Full Text] [Related]
17. Isolation and initial characterization of the BRCA2 promoter.
Davis PL; Miron A; Andersen LM; Iglehart JD; Marks JR
Oncogene; 1999 Oct; 18(44):6000-12. PubMed ID: 10557089
[TBL] [Abstract][Full Text] [Related]
18. Highly conserved proximal promoter element harbouring paired Sox9-binding sites contributes to the tissue- and developmental stage-specific activity of the matrilin-1 gene.
Rentsendorj O; Nagy A; Sinkó I; Daraba A; Barta E; Kiss I
Biochem J; 2005 Aug; 389(Pt 3):705-16. PubMed ID: 15804237
[TBL] [Abstract][Full Text] [Related]
19. Binding of two nuclear factors to a novel silencer element in human dentin matrix protein 1 (DMP1) promoter regulates the cell type-specific DMP1 gene expression.
Chen S; Inozentseva-Clayton N; Dong J; Gu TT; MacDougall M
J Cell Biochem; 2004 May; 92(2):332-49. PubMed ID: 15108359
[TBL] [Abstract][Full Text] [Related]
20. ATF1 and CREB trans-activate a cell cycle regulated histone H4 gene at a distal nuclear matrix associated promoter element.
Guo B; Stein JL; van Wijnen AJ; Stein GS
Biochemistry; 1997 Nov; 36(47):14447-55. PubMed ID: 9398163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
